Literature DB >> 2975945

Insulin proteinase liberates from glucagon a fragment known to have enhanced activity against Ca2+ + Mg2+-dependent ATPase.

K Rose1, L A Savoy, A V Muir, J G Davies, R E Offord, G Turcatti.   

Abstract

We find, contrary to previous reports, that substantial cleavage of glucagon by insulin proteinase occurs at only one region, namely the double-basic sequence -Arg17-Arg18-. Cleavage takes place almost exclusively between these two residues, liberating fragments glucagon-(1-17) and glucagon-(18-29). Others have shown that the fragment glucagon-(19-29) is 1000-fold more efficient compared with intact glucagon, at inhibiting the Ca2+-activated and Mg2+-dependent ATPase activity and the Ca2+ pump of liver plasma membranes. We show that this fragment is not liberated in detectable quantities by our insulin proteinase preparation. On the other hand, others have shown that glucagon-(18-29), though less active than glucagon-(19-29), was still 100-fold more active than glucagon itself in the above-mentioned system. Our observations represent the first demonstration of the release by insulin proteinase of a hormone fragment having enhanced activity, although it has yet to be shown that the activity of this fragment is important in vivo. Since the formation of glucagon-(19-29) from glucagon-(18-29) would involve merely removal of Arg18, a second enzyme might exist to provide the more active fragment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2975945      PMCID: PMC1135493          DOI: 10.1042/bj2560847

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  13 in total

1.  Sites of cleavage of glucagon by insulin-glucagon protease.

Authors:  F K Baskin; W C Duckworth; A E Kitabchi
Journal:  Biochem Biophys Res Commun       Date:  1975-11-03       Impact factor: 3.575

2.  Proteolytic degradation of insulin and glucagon.

Authors:  W C Duckworth; M Heinemann; A E Kitabchi
Journal:  Biochim Biophys Acta       Date:  1975-02-19

3.  In vivo association of [125I]-insulin with a cytosolic insulin-degrading enzyme: detection by covalent cross-linking and immunoprecipitation with a monoclonal antibody.

Authors:  J Hari; K Shii; R A Roth
Journal:  Endocrinology       Date:  1987-02       Impact factor: 4.736

4.  Identification of some cleavage sites of insulin by insulin proteinase.

Authors:  J G Davies; A V Muir; R E Offord
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

5.  C-terminal peptide identification by fast atom bombardment mass spectrometry.

Authors:  K Rose; L A Savoy; M G Simona; R E Offord; P Wingfield
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

6.  Reduction of sulfoxides in peptides and proteins.

Authors:  R A Houghten; C H Li
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

Review 7.  Insulin metabolism and degradation.

Authors:  W C Duckworth; A E Kitabchi
Journal:  Endocr Rev       Date:  1981       Impact factor: 19.871

8.  Purification and characterization of a rat liver cytosol neutral thiol peptidase that degrades glucagon, insulin, and isolated insulin A and B chains.

Authors:  L A Shroyer; P T Varandani
Journal:  Arch Biochem Biophys       Date:  1985-01       Impact factor: 4.013

9.  A glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagon.

Authors:  A Mallat; C Pavoine; M Dufour; S Lotersztajn; D Bataille; F Pecker
Journal:  Nature       Date:  1987 Feb 12-18       Impact factor: 49.962

10.  Detection of somatic changes in human cancer DNA by DNA fingerprint analysis.

Authors:  S L Thein; A J Jeffreys; H C Gooi; F Cotter; J Flint; N T O'Connor; D J Weatherall; J S Wainscoat
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640

View more
  8 in total

1.  Characterization of the bacterial metalloendopeptidase pitrilysin by use of a continuous fluorescence assay.

Authors:  A Anastasi; C G Knight; A J Barrett
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

Review 2.  Physiological functions of endosomal proteolysis.

Authors:  T Berg; T Gjøen; O Bakke
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

3.  Preparation and characterization of novel substrates of insulin proteinase (EC 3.4.99.45).

Authors:  R C Werlen; R E Offord; K Rose
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

4.  Link peptide cartilage growth factor is degraded by membrane proteinases.

Authors:  M F Dean; P Sansom
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

5.  Molecular bases for the recognition of short peptide substrates and cysteine-directed modifications of human insulin-degrading enzyme.

Authors:  Enrico Malito; Luis A Ralat; Marika Manolopoulou; Julie L Tsay; Natasha L Wadlington; Wei-Jen Tang
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

6.  Degradation of glucagon in isolated liver endosomes. ATP-dependence and partial characterization of degradation products.

Authors:  F Authier; B Desbuquois
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

7.  Structure based discovery of small molecules to regulate the activity of human insulin degrading enzyme.

Authors:  Bilal Çakir; Onur Dağliyan; Ezgi Dağyildiz; İbrahim Bariş; Ibrahim Halil Kavakli; Seda Kizilel; Metin Türkay
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

8.  Bile acid TUDCA improves insulin clearance by increasing the expression of insulin-degrading enzyme in the liver of obese mice.

Authors:  Jean Franciesco Vettorazzi; Mirian Ayumi Kurauti; Gabriela Moreira Soares; Patricia Cristine Borck; Sandra Mara Ferreira; Renato Chaves Souto Branco; Luciana de Souza Lima Michelone; Antonio Carlos Boschero; Jose Maria Costa Junior; Everardo Magalhães Carneiro
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.